Loading…
Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice
ATP-sensitive K + (K ATP ) channels regulate many cellular functions by linking cell metabolism to membrane potential. We have generated K ATP channel-deficient mice by genetic disruption of Kir6.2, which forms the K + ion-selective pore of the channel. The homozygous mice (Kir6.2 −/− ) lack K ATP c...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS 1998-09, Vol.95 (18), p.10402-10406 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | ATP-sensitive K + (K ATP ) channels regulate many cellular functions by linking cell metabolism to membrane potential. We have generated K ATP channel-deficient mice by genetic disruption of Kir6.2, which forms the K + ion-selective pore of the channel. The homozygous mice (Kir6.2 −/− ) lack K ATP channel activity. Although the resting membrane potential and basal intracellular calcium concentrations ([Ca 2+ ] i ) of pancreatic beta cells in Kir6.2 −/− are significantly higher than those in control mice (Kir6.2 +/+ ), neither glucose at high concentrations nor the sulfonylurea tolbutamide elicits a rise in [Ca 2+ ] i , and no significant insulin secretion in response to either glucose or tolbutamide is found in Kir6.2 −/− , as assessed by perifusion and batch incubation of pancreatic islets. Despite the defect in glucose-induced insulin secretion, Kir6.2 −/− show only mild impairment in glucose tolerance. The glucose-lowering effect of insulin, as assessed by an insulin tolerance test, is increased significantly in Kir6.2 −/− , which could protect Kir6.2 −/− from developing hyperglycemia. Our data indicate that the K ATP channel in pancreatic beta cells is a key regulator of both glucose- and sulfonylurea-induced insulin secretion and suggest also that the K ATP channel in skeletal muscle might be involved in insulin action. sulfonylurea receptor/inward rectifier/gene targeting |
---|---|
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.95.18.10402 |